Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis.
Treatment and control of schistosomiasis relies on the only available drug, praziquantel, and the search for alternative chemotherapeutic agents is therefore urgent. Egg production is required for the transmission and immunopathology of schistosomiasis and females of S. mansoni lay 300 eggs daily. A...
Main Authors: | Vitor Coutinho Carneiro, Isabel Caetano de Abreu da Silva, Eduardo José Lopes Torres, Stephany Caby, Julien Lancelot, Mathieu Vanderstraete, Silviya D Furdas, Manfred Jung, Raymond J Pierce, Marcelo Rosado Fantappié |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-05-01
|
Series: | PLoS Pathogens |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24809504/pdf/?tool=EBI |
Similar Items
-
Epigenetic control of gene function in schistosomes: a source of therapeutic targets?
by: Raymond John Pierce, et al.
Published: (2014-09-01) -
Chromatin regulation in schistosomes and histone modifying enzymes as drug targets
by: Raymond John Pierce, et al.
Published: (2011-11-01) -
Role of MicroRNAs in Schistosomes and Schistosomiasis
by: Lihui eZhu, et al.
Published: (2014-11-01) -
Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.
by: Mathieu Vanderstraete, et al.
Published: (2013-01-01) -
Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis
by: Marion Morel, et al.
Published: (2014-12-01)